These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28190386)

  • 1. High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes.
    Androulakis E; Zacharia E; Papageorgiou N; Lioudaki E; Bertsias D; Charakida M; Siasos G; Tousoulis D
    Curr Cardiol Rev; 2017; 13(3):168-182. PubMed ID: 28190386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes.
    Meeusen JW; Donato LJ; Jaffe AS
    Curr Cardiol Rep; 2017 Jun; 19(6):48. PubMed ID: 28432661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value and distribution of high-density lipoprotein subclass in patients with acute coronary syndrome.
    Tian L; Li C; Liu Y; Chen Y; Fu M
    PLoS One; 2014; 9(1):e85114. PubMed ID: 24465490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).
    Ballantyne CM; Pitt B; Loscalzo J; Cain VA; Raichlen JS
    Am J Cardiol; 2013 Feb; 111(4):506-9. PubMed ID: 23237107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease.
    Meikle PJ; Formosa MF; Mellett NA; Jayawardana KS; Giles C; Bertovic DA; Jennings GL; Childs W; Reddy M; Carey AL; Baradi A; Nanayakkara S; Wilson AM; Duffy SJ; Kingwell BA
    J Am Heart Assoc; 2019 Jun; 8(11):e011792. PubMed ID: 31131674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting high-density lipoproteins: update on a promising therapy.
    Verdier C; Martinez LO; Ferrières J; Elbaz M; Genoux A; Perret B
    Arch Cardiovasc Dis; 2013 Nov; 106(11):601-11. PubMed ID: 24074699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidized low-density lipoprotein-induced CD147 expression and its inhibition by high-density lipoprotein on platelets in vitro.
    Yang SH; Li YT; Du DY
    Thromb Res; 2013; 132(6):702-11. PubMed ID: 24144446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of lipid management in acute coronary syndrome.
    Fujisue K; Tsujita K
    J Cardiol; 2017 Aug; 70(2):101-106. PubMed ID: 28325524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
    Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
    Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microencapsulated Pomegranate Reverts High-Density Lipoprotein (HDL)-Induced Endothelial Dysfunction and Reduces Postprandial Triglyceridemia in Women with Acute Coronary Syndrome.
    Estrada-Luna D; Carreón-Torres E; Bautista-Pérez R; Betanzos-Cabrera G; Dorantes-Morales A; Luna-Luna M; Vargas-Barrón J; Mejía AM; Fragoso JM; Carvajal-Aguilera K; García-Trejo JJ; Vargas-Alarcón G; Pérez-Méndez Ó
    Nutrients; 2019 Jul; 11(8):. PubMed ID: 31349559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
    Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes.
    Roe MT; Ou FS; Alexander KP; Newby LK; Foody JM; Gibler WB; Boden WE; Ohman EM; Smith SC; Peterson ED
    Eur Heart J; 2008 Oct; 29(20):2480-8. PubMed ID: 18716006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of short-term low-dose atorvastatin on low-density lipoprotein and high-density lipoprotein subfraction phenotype.
    Xu RX; Guo YL; Li XL; Li S; Li JJ
    Clin Exp Pharmacol Physiol; 2014 Jul; 41(7):475-81. PubMed ID: 24739131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focus on high-density lipoproteins in reducing cardiovascular risk.
    Brewer HB
    Am Heart J; 2004 Jul; 148(1 Suppl):S14-8. PubMed ID: 15211328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial.
    Albers JJ; Slee A; Fleg JL; O'Brien KD; Marcovina SM
    Atherosclerosis; 2016 Aug; 251():454-459. PubMed ID: 27320173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstituted HDL in acute coronary syndromes.
    Chenevard R; Hürlimann D; Spieker L; Béchir M; Enseleit F; Hermann M; Flammer AJ; Sudano I; Corti R; Lüscher TF; Noll G; Ruschitzka F
    Cardiovasc Ther; 2012 Apr; 30(2):e51-7. PubMed ID: 20840194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density Lipoprotein (HDL) Dysfunction and the Future of HDL.
    Ertek S
    Curr Vasc Pharmacol; 2018; 16(5):490-498. PubMed ID: 29149817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.